References
- Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlation of telomerase activity level with human neuroblastoma outcome. Nature Med 1995; 1: 249–55
- Dalbagni G, Han W, Zhang ZF, Cordon-Cardo C, Saigo P, Fair WR, et al. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clin Cancer Res 1997; 3: 1593–8
- Hiyama K, Kirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711–5
- Holt SE, Wright WE, Shay JW. Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 1996; 95: 90–2
- Min WS, Jung HS, Park JY, Jun BH, Song GY. Immunohistochemical study on the expression of proliferative markers of the squamous epithelium of the cholesteatoma. Korean J Otolaryngol 1995; 38: 1884–92
- Tanaka Y, Shima M, Kojima H, Miyazaki H, Kamide Y, Moriyama H. A study on epithelial proliferation ability in cholesteatoma. Laryngoscope 1998; 108: 537–41
- Blackburn EH. Structure and function of telomerase. Nature 1991; 350: 569–73
- Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with aging. Mol Cell Biol 1989; 9: 345–8
- Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787–91
- Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011–5
- Wright W, Piatyszek K, Rainey W, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996; 18: 173–9
- Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci U S A 1996; 93: 6476–81
- Kannan S, Tahara H, Yokozaki H, Mathew B, Nalinakumari KR, Nair MK, et al. Telomerase activity in premalignant and malignant lesions of human oral mucosa. Cancer Epiderm Biomarkers Prev 1997; 6: 413–20
- Tae K, Ahn MJ, Lee HS, Park BJ, Ahn KS. Telomerase activity in oral leukoplakia tissues. Korean J Otolaryngol 1999; 42: 82–7
- Kyo S, Takakura M, Kohoma T, Inoue M. Telomerase activity in human endometrium. Cancer Res 1997; 57: 610–4
- Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 1996; 106: 759–65
- Albino AP, Kimmelman CP, Parisier SC. Cholesteatoma: a molecular and cellular puzzle. Am J Otol 1998; 19: 7–19
- Bernal Sprekelsen M, Ebmeyer J, Buchbinder A, Sudhoff H. Comparative analysis of the proliferative capacity of cholesteatomas. Acta Otorrinolaringol Esp 2000; 51: 299–307
- Watabe-Rudolph M, Rudolph KL, Averbeck T, Buhr T, Lenarz T, Stover T. Telomerase activity, telomere length, and apoptosis: a comparison between acquired cholesteatoma and squamous cell carcinoma. Otol Neurotol 2002; 23: 793–8
- Goh E, Lee B, Wang S, Chon K, Kim C. Expression of telomerase activity in cholesteatoma otitis media. J Laryngol Otol 2001; 115: 881–4
- Kojima H, Miyazaki H, Shiwa M, Tanaka Y, Morlyama H. Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length. Laryngoscope 2001; 111: 867–73
- Kojima H, Tanaka Y, Tanaka T, Miyazaki H, Shiwa M, Kamide Y, et al. Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 1998; 124: 261–4
- Chae SW, Song JJ, Suh HK, Jung HH, Lim HH, Hwang SJ. Expression patterns of p27 and Ki-67 in cholesteatoma epithelium. Laryngoscope 2000; 10: 1898–901
- Ogoshi M, Le T, Shay JW, Taylor RS. In situ hybridization analysis of the expression of human telomerase RNA in normal and pathologic conditions of the skin. J Invest Dermatol 1998; 110: 818–23
- Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168: 357–63